Opinion
3dOpinion
Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why
(THE CONVERSATION) The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the ...
Understanding how genetic and metabolic dysregulations influence aging process has become one of the most interesting topics in biomedical ...
The market is hopping with interesting news.
Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into a variety of cell types including osteoblasts, chondrocytes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback